ESR1 and breast cancer: In turn, a specific siRNA for IGF-1R prevents adiponectin-induced ERα transactivation, thus proving the existence of a functional interplay among adiponectin/AdipoR1, ERα, and IGF-1R, promoting ERα+ breast cancer cell growth [60,115].